Investing in tomorrow's medicine
Mérieux Equity Partners is a global investment platform specialized in the healthcare & nutrition sector, working alongside entrepreneurs and companies with ambitious growth plan, offering them privileged access to sector-expertise and industrial network.
MRM Health appoints Dr. Werner Cautreels as Chairman and Dr. Nigel Horscroft as Chief Scientific Officer
Dr. Werner Cautreels, former CEO of Solvay Pharmaceuticals and Selecta Biosciences, has been appointed as Chairman of the Board and Dr. Nigel Horscroft, ex-Curevac and Pfizer, as Chief Scientific Officer. In addition, Dr. Ludo Haazen is joining the R&D organization to support clinical development and medical affairs.
Mérieux Equity Partners and Korys announce the launch of OMX Europe Venture Fund, dedicated to Venture investment within the healthcare and nutrition sectors
The new investment platform in Venture Capital will support innovative companies in the healthcare and nutrition sectors, in Europe and North America.